Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
about
The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimism(A)symmetric stem cell replication and cancerAdvanced colonoscopic imaging using endocytoscopy.B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P.Affibody-functionalized gold-silica nanoparticles for Raman molecular imaging of the epidermal growth factor receptor.NSAIDs and Colorectal Cancer Control: Promise and ChallengesAssociation of visceral obesity and early colorectal neoplasia.Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis.Molecular imaging of aberrant crypt foci in the human colon targeting glutathione S-transferase P1-1.Keratin 8-deletion induced colitis predisposes to murine colorectal cancer enforced by the inflammasome and IL-22 pathway.The G-protein coupled receptor 56, expressed in colonic stem and cancer cells, binds progastrin to promote proliferation and carcinogenesis.Microdevice to capture colon crypts for in vitro studies.Transgenic alfalfa that accumulates piceid (trans-resveratrol-3-O-beta-D-glucopyranoside) requires the presence of beta-glucosidase to inhibit the formation of aberrant crypt foci in the colon of CF-1 mice.Chemoprevention of colonic tumorigenesis by dietary hydroxylated polymethoxyflavones in azoxymethane-treated mice.Optimizing Wnt-3a and R-spondin1 concentrations for stem cell renewal and differentiation in intestinal organoids using a gradient-forming microdeviceDetection of aberrant crypt foci with image-enhanced endoscopy
P2860
Q28087427-59D3A545-F850-4728-9F37-41255500251FQ33279153-B6E6A73B-A080-408F-A877-1C427AB2C1C2Q35328620-99BFB878-E49E-49AA-A3EA-49EB76D668E9Q35677252-F182065A-63A8-4EA6-A558-E87AA4E41A25Q36066747-3B1A7694-BCAB-4930-B9B0-B0746D85B052Q36381490-3C003F95-DAEE-46F1-9B95-45EBDC15F443Q37378956-C9C2DFFF-5766-4E76-86E5-00F4BF439B2EQ37890253-9AEE2C93-F936-4006-8862-654AD3D51F65Q38696314-7C6F4C93-C98B-42E7-9189-B9571578EB30Q38768002-7BBE76F6-7486-4A16-9EF8-FFF4B2B251C9Q41092567-A1E52632-C266-433A-A2AB-BF5B8603E1EAQ41491485-FE448D43-6BAD-4122-A863-9B362C2BB3F5Q42514125-23543D5B-1606-49E2-956B-D0D410A4F51DQ51755634-B31A1DC2-75CC-4183-A3B9-2381E9FE1E6CQ57439464-93C6AA59-6E73-47A5-84F0-1A261564A84FQ58805741-DED81C8E-BA47-4598-9555-2969FBE4FCAB
P2860
Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
@ast
Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
@en
Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
@nl
type
label
Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
@ast
Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
@en
Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
@nl
prefLabel
Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
@ast
Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
@en
Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
@nl
P2093
P1476
Aberrant crypt foci: detection, gene abnormalities, and clinical usefulness.
@en
P2093
Hirotoshi Ishiwatari
Koji Miyanishi
Kunihiro Takanashi
Takahiro Kogawa
Takehiro Kukitsu
Tetsuji Takayama
Tomoyuki Abe
Tsuyoshi Hayashi
Yoshiro Niitsu
P356
10.1016/S1542-3565(05)00257-0
P407
P433
P577
2005-07-01T00:00:00Z